Cargando…

Evaluation of ultra-early and dose-dependent edema and ultrastructural changes in the myocyte during anti-hypertensive drug delivery in the spontaneously hypertensive rat model

BACKGROUND: Quantifying dose-dependent ultra-early edema and ultrastructural changes in the myocyte after drug delivery is important for the development of new mixed calcium channel blockers (CCBs). MATERIALS AND METHODS: Arterial cannulation was used to measure mean arterial pressure in real time;...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Hua, Wang, Yuqing, Cai, Wei, He, Chengqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162487/
https://www.ncbi.nlm.nih.gov/pubmed/32298274
http://dx.doi.org/10.1371/journal.pone.0231244
_version_ 1783523041853046784
author Guo, Hua
Wang, Yuqing
Cai, Wei
He, Chengqi
author_facet Guo, Hua
Wang, Yuqing
Cai, Wei
He, Chengqi
author_sort Guo, Hua
collection PubMed
description BACKGROUND: Quantifying dose-dependent ultra-early edema and ultrastructural changes in the myocyte after drug delivery is important for the development of new mixed calcium channel blockers (CCBs). MATERIALS AND METHODS: Arterial cannulation was used to measure mean arterial pressure in real time; simultaneously, magnetic resonance imaging proton density mapping was used to quantify edema 5–55 min after the delivery of L-type CCBs, T- and L-type CCBs, and solvent to a spontaneously hypertensive rat model. Transmission electron microscopy was used to show ultrastructural changes in the myocyte. RESULTS: Analysis of variance showed significant differences among the three groups in mean arterial pressure reduction (F = 246.36, P = 5.75E(-25)), ultra-early level of edema (ULE) (F = 175.49, P = 5.62E(-22)), and dose-dependent level of edema (DLE) (F = 199.48, P = 4.28E(-23)). Compared with the solvent’s mean arterial pressure reduction (2.65±6.56±1.64), ULE (1.16±0.09±0.02), and DLE (0.0010±0.0001±0.0000), post hoc tests showed that T- and L-type CCBs had better mean arterial pressure reduction (90.67±11.58±2.90, P = 1.06E(-24) vs. 68.34±15.19±3.80, P = 1.76E(-12)), lower ULE (1.53±0.14±0.04, P = 4.74E(-9) vs. 2.08±0.18±0.04, P = 2.68E(-22)), and lower DLE (0.0025±0.0004±0.0001, P = 1.14E(-11) vs. 0.0047±0.0008±0.0002, P = 2.10E(-11)) than L- type CCBs. Transmission electron microscopy showed that T- and L-type CCBs caused fewer ultrastructural changes in the myocytes after drug delivery than L-type CCBs. CONCLUSION: T- and L-type CCBs produced less ultra-early and dose-dependent edema, fewer ultrastructural changes in the myocyte, and a greater antihypertensive effect. Proton density mapping combined with arterial cannulation and transmission electron microscopy allowed for quantification of ultra-early and dose-dependent edema, antihypertensive efficacy, and ultrastructural changes in the myocyte. This is important for the evaluation of induced vasodilatory edema.
format Online
Article
Text
id pubmed-7162487
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-71624872020-04-21 Evaluation of ultra-early and dose-dependent edema and ultrastructural changes in the myocyte during anti-hypertensive drug delivery in the spontaneously hypertensive rat model Guo, Hua Wang, Yuqing Cai, Wei He, Chengqi PLoS One Research Article BACKGROUND: Quantifying dose-dependent ultra-early edema and ultrastructural changes in the myocyte after drug delivery is important for the development of new mixed calcium channel blockers (CCBs). MATERIALS AND METHODS: Arterial cannulation was used to measure mean arterial pressure in real time; simultaneously, magnetic resonance imaging proton density mapping was used to quantify edema 5–55 min after the delivery of L-type CCBs, T- and L-type CCBs, and solvent to a spontaneously hypertensive rat model. Transmission electron microscopy was used to show ultrastructural changes in the myocyte. RESULTS: Analysis of variance showed significant differences among the three groups in mean arterial pressure reduction (F = 246.36, P = 5.75E(-25)), ultra-early level of edema (ULE) (F = 175.49, P = 5.62E(-22)), and dose-dependent level of edema (DLE) (F = 199.48, P = 4.28E(-23)). Compared with the solvent’s mean arterial pressure reduction (2.65±6.56±1.64), ULE (1.16±0.09±0.02), and DLE (0.0010±0.0001±0.0000), post hoc tests showed that T- and L-type CCBs had better mean arterial pressure reduction (90.67±11.58±2.90, P = 1.06E(-24) vs. 68.34±15.19±3.80, P = 1.76E(-12)), lower ULE (1.53±0.14±0.04, P = 4.74E(-9) vs. 2.08±0.18±0.04, P = 2.68E(-22)), and lower DLE (0.0025±0.0004±0.0001, P = 1.14E(-11) vs. 0.0047±0.0008±0.0002, P = 2.10E(-11)) than L- type CCBs. Transmission electron microscopy showed that T- and L-type CCBs caused fewer ultrastructural changes in the myocytes after drug delivery than L-type CCBs. CONCLUSION: T- and L-type CCBs produced less ultra-early and dose-dependent edema, fewer ultrastructural changes in the myocyte, and a greater antihypertensive effect. Proton density mapping combined with arterial cannulation and transmission electron microscopy allowed for quantification of ultra-early and dose-dependent edema, antihypertensive efficacy, and ultrastructural changes in the myocyte. This is important for the evaluation of induced vasodilatory edema. Public Library of Science 2020-04-16 /pmc/articles/PMC7162487/ /pubmed/32298274 http://dx.doi.org/10.1371/journal.pone.0231244 Text en © 2020 Guo et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Guo, Hua
Wang, Yuqing
Cai, Wei
He, Chengqi
Evaluation of ultra-early and dose-dependent edema and ultrastructural changes in the myocyte during anti-hypertensive drug delivery in the spontaneously hypertensive rat model
title Evaluation of ultra-early and dose-dependent edema and ultrastructural changes in the myocyte during anti-hypertensive drug delivery in the spontaneously hypertensive rat model
title_full Evaluation of ultra-early and dose-dependent edema and ultrastructural changes in the myocyte during anti-hypertensive drug delivery in the spontaneously hypertensive rat model
title_fullStr Evaluation of ultra-early and dose-dependent edema and ultrastructural changes in the myocyte during anti-hypertensive drug delivery in the spontaneously hypertensive rat model
title_full_unstemmed Evaluation of ultra-early and dose-dependent edema and ultrastructural changes in the myocyte during anti-hypertensive drug delivery in the spontaneously hypertensive rat model
title_short Evaluation of ultra-early and dose-dependent edema and ultrastructural changes in the myocyte during anti-hypertensive drug delivery in the spontaneously hypertensive rat model
title_sort evaluation of ultra-early and dose-dependent edema and ultrastructural changes in the myocyte during anti-hypertensive drug delivery in the spontaneously hypertensive rat model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162487/
https://www.ncbi.nlm.nih.gov/pubmed/32298274
http://dx.doi.org/10.1371/journal.pone.0231244
work_keys_str_mv AT guohua evaluationofultraearlyanddosedependentedemaandultrastructuralchangesinthemyocyteduringantihypertensivedrugdeliveryinthespontaneouslyhypertensiveratmodel
AT wangyuqing evaluationofultraearlyanddosedependentedemaandultrastructuralchangesinthemyocyteduringantihypertensivedrugdeliveryinthespontaneouslyhypertensiveratmodel
AT caiwei evaluationofultraearlyanddosedependentedemaandultrastructuralchangesinthemyocyteduringantihypertensivedrugdeliveryinthespontaneouslyhypertensiveratmodel
AT hechengqi evaluationofultraearlyanddosedependentedemaandultrastructuralchangesinthemyocyteduringantihypertensivedrugdeliveryinthespontaneouslyhypertensiveratmodel